个人简介
Thomas Smith, M.D., is a professor of oncology at the Johns Hopkins University School of Medicine, director of Palliative Medicine for Johns Hopkins Medicine and the Harry J. Duffey Family Professor of Palliative Care.
He is a medical oncologist and a palliative care specialist with a lifelong interest in better symptom management, communication, and improving access to high quality affordable care. Dr. Smith began Johns Hopkins' hospital-wide palliative care consult service as well as an inpatient unit, and he is dedicated to accelerating palliative care research and education.
Dr. Smith is a Fellow in the American Society of Clinical Oncology (ASCO) and the American Association of Hospice and Palliative Medicine (AAHPM) and is listed among the top oncologists in the country. He is publishing the Oxford Textbook of Communication and the Geriatric Clinics update on Palliative care. He has taught end of life concepts in more than a dozen countries and helped create the Oncology Module for the Center to Advance Palliative Care (CAPC) Palliative Care Leadership Centers curriculum.
Dr. Smith received his M.D. from Yale Medical School and completed his residency at the University of Pennsylvania and a fellowship in oncology and hematology at the Virginia Commonwealth University School of Medicine. He joined the faculty at Johns Hopkins in 2011.
近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Smith T: Fatty Replacement of Lymph Nodes Mimicking Lymphoma Relapse. Cancer. 1986;68(12): 2686-2688
Smith T: Acute Tumor Lysis Syndrome Following Platelet Transfusion. Virginia Med. 1986;113:100-101
Smith T, Clark JW, Popp MB: Regression of Tumor Nodules in a Patient Treated with Ranitidine. Arch Int Med. 1987;147(10): 1815-1816
Smith T: Tumor Lysis Syndrome after Steroid Therapy for Anaphylaxis. S Med J. 1988; 81(3):415-416
Smith T: H2 Receptor Antagonists and Cancer Immunotherapy. Comprehensive Therapy. 1990;16:8-13
Smith T, Grossberg HG: Successful Use of Granulocyte-Macrophage Colony Stimulating Factor in Patients with Acute Lymphocytic Leukemia. Am J Med. 1990;89:384-386.
Smith T, Kaplowitz LG: Treatment of Kaposi's Sarcoma in AIDS Patients with Cimetidine. JNCI. 1991; 83:139-141
Smith TJ, Desch CE. Neutropenia-wise and pound-foolish: care of the massively obese chemotherapy patient. S Med . 1991; 84:883-885
Hillner BE, Smith T. Efficacy and cost-effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision analysis model. N Engl J Med. 1991; 324:160-168.
Smith T, Desch C, Simonson C, Kane N. Teaching subspecialty medicine in a rural hospital. J Cancer Educ. 1991: 6:1-6
Smith T, Desch CE, Kaplowitz LG. Pulmonary Disease in the AIDS Patients with Kaposi's sarcoma. Infections in Med. 1992; 9(2):10-16
Desch CE, Lasala MR, Smith T, Hillner BE. The Optimal Timing of Autologous Bone Marrow Transplantation in Hodgkin's Disease Patients Following a Chemotherapy Relapse. J Clin Oncol. 1992; 10:200-209
Smith T, Brown PA. The Cancer Information Service: What it can do for you. Indian Health Service Provider. 1991;16(10):156-157
Desch CE, Smith TJ, Briendel CA, Simonson CJ, Kane N. Cancer Treatment in Rural Areas. Hospital and Health Services Admin. 1992; 37:449-463
Hillner BE, Smith TJ, Desch CE. Efficacy and Cost-Effectiveness of Autologous Bone Marrow Transplantation in Metastatic Breast Cancer -- Estimates using decision analysis while awaiting clinical trial results. JAMA. 1992;267:2055-2062
Hillner BE, Smith TJ. Should women with node-negative breast cancer receive adjuvant chemotherapy? Insights from a decision analysis model. Breast Cancer Research and Treatment. 1992; 23:17-27
Desch CE, Hillner BE, Smith TJ, Retchin SR. Should the elderly receive chemotherapy for node- negative breast cancer? A Cost -Effectiveness Analysis Examining Total and Active Life- Expectancy Outcomes. J Clin Oncol. 1993; 11:777-782
Smith TJ, Hillner BE. The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women. J Clin Oncol. 1993; 11:771-776, 1993.
Hillner BE, Smith TJ, Desch CE. Assessing the cost effectiveness analysis of adjuvant therapies in early breast cancer using a decision analysis model. Breast Cancer Research and Treatment, 1993; 25:97-105
Smith TJ, Desch CE, Hillner BE. Efficacy and Cost-effectiveness in Oncology: Rational Allocation of Cancer Care Resources. JNCI. 1993; 85:1460-71
Smith TJ. Which Hat Do I Wear? Discussing Costs of Breast Cancer Treatment with Patients. JAMA. 1993; 270:1657-1659
Smith TJ, Desch CE, Hillner BH. Ways to reduce the cost of oncology care without compromising the quality. Cancer Investigation. 1994; 12:257-265
Hillner BE, Smith TJ, Desch CE. Principles of cost effectiveness analysis for the assessment of current and new therapies. J Hematherapy. 1993; 2:501-506
Hillner BE, Smith TJ, Desch CE. Cost-effective use of autologous bone marrow transplantation: few answers, many questions, and suggestions for future assessments. Pharmacoeconomics.1994; 6:114-126
Hampton CL, Mazmanian PE, Smith TJ. Applying telecommunications technology: a case study of a videoconference to disseminate breast cancer guidelines. J Continuing Educ in the Professions. 1994; 14:83-89,
京公网安备 11010802027423号